Menopause Care Reaches New York Women with Elektra Health as the Leading Insurance-Covered Provider
With addition of Fidelis Care and MetroPlusHealth, Elektra Health now available to over 95% of women insured through commercial, Medicare...
With addition of Fidelis Care and MetroPlusHealth, Elektra Health now available to over 95% of women insured through commercial, Medicare...
BOSTON, Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion...
LEXINGTON, Ky., Sept. 22, 2025 /PRNewswire/ -- Thynk Health, a leading innovator in AI-powered diagnostic platforms, today announced the appointment...
Home care company adds seasoned franchise and technology executives to fuel expansion and enhance data-driven senior care management SAN ANTONIO,...
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global...
FRANKLIN LAKES, N.J., Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,...
Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio GRAND RAPIDS, Mich., Sept. 22, 2025...
NORTHAMPTON, MA / ACCESS Newswire / September 22, 2025 / MilliporeSigma, the U.S. and Canada Life Science business of Merck...
Legal & regulatory executive with extensive expertise in FDA law and regulatory leadership for one of the world's leading medical...
MESA, ARIZONA / ACCESS Newswire / September 22, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a significant...
THOUSAND OAKS, CA / ACCESS Newswire / September 22, 2025 / After months of anticipation, The Midwife & More proudly...
MESA, ARIZONA / ACCESS Newswire / September 22, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a significant...
SAN FRANCISCO, CA / ACCESS Newswire / September 22, 2025 / MentalHealth.com today announced its acquisition of Therapy.ai, a move...
Study demonstrated Ketamir-2 was safe and well tolerated at all dose levels, with a favorable safety and tolerability profile, with...
Elraglusib represents a potential back bone therapy in pancreatic cancer with three ongoing trials in combination with current standards of...
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)...
Dr. Raymond Turner is a board-certified endovascular neurosurgeon with more than 20 years of surgical practice Dr. Raymond Turner Dr. Turner...
New data address critical treatment gap for millions of Americans with COPD who face unique smoking cessation challengesSEATTLE and VANCOUVER,...
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based...
LONDON and NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which...